| 000 | 01539 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516033946.0 | ||
| 264 | 0 | _c20110722 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1744-8042 | ||
| 024 | 7 |
_a10.2217/pgs.10.202 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Huijuan | |
| 245 | 0 | 0 |
_aAssociation analysis of CYP2A6 genotypes and haplotypes with 5-fluorouracil formation from tegafur in human liver microsomes. _h[electronic resource] |
| 260 |
_bPharmacogenomics _cApr 2011 |
||
| 300 |
_a481-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xpharmacokinetics |
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xgenetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2A6 |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xmetabolism |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHaplotypes _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xenzymology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aTegafur _xpharmacokinetics |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBian, Ting | |
| 700 | 1 | _aLiu, Duan | |
| 700 | 1 | _aJin, Tianbo | |
| 700 | 1 | _aChen, Yong | |
| 700 | 1 | _aLin, Aifen | |
| 700 | 1 | _aChen, Chao | |
| 773 | 0 |
_tPharmacogenomics _gvol. 12 _gno. 4 _gp. 481-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs.10.202 _zAvailable from publisher's website |
| 999 |
_c20785966 _d20785966 |
||